Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic osteodystrophy

R G Long, M R Wills

    British Journal of Hospital Medicine
    |September 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Hepatic osteodystrophy involves osteomalacia, osteoporosis, and new bone formation. Vitamin D deficiency causes osteomalacia, treatable with supplements, while other forms remain unclear.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Responding to the post-pandemic crisis: post-exposure prophylaxis for TB.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
    Same author

    Functional cell phenotype induction with TGF-β1 and collagen-polyurethane scaffold for annulus fibrosus rupture repair.

    European cells & materials·2020
    Same author

    Advances in the treatment of cytomegalovirus.

    British medical bulletin·2019
    Same author

    Thermoresponsive, redox-polymerized cellulosic hydrogels undergo in situ gelation and restore intervertebral disc biomechanics post discectomy.

    European cells & materials·2018
    Same author

    A Coagulation Defect in Amyloidosis.

    The Medical journal of the South-West·2017
    Same author

    LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latency.

    Scientific reports·2017
    Same journal

    The autopsy in the 1990s.

    British journal of hospital medicine·1999
    Same journal

    Screening for breast cancer.

    British journal of hospital medicine·1999
    Same journal

    Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

    British journal of hospital medicine·1999
    Same journal

    Liposarcoma: a review of current diagnosis and management.

    British journal of hospital medicine·1999
    Same journal

    How to do it in surgery: laparoscopic rectopexy.

    British journal of hospital medicine·1999
    Same journal

    The management of ovarian cancer.

    British journal of hospital medicine·1999
    See all related articles

    Area of Science:

    • Hepatology
    • Endocrinology
    • Bone Metabolism

    Background:

    • Hepatic osteodystrophy presents as osteomalacia, osteoporosis, and periosteal reactions.
    • Secondary hyperparathyroidism is uncommon in this condition.
    • Osteomalacia is linked to vitamin D deficiency, impacting calcium and phosphorus absorption.

    Purpose of the Study:

    • To elucidate the causes and treatment of hepatic osteodystrophy subtypes.
    • To investigate the role of vitamin D deficiency in osteomalacia.
    • To explore the etiology and management of osteoporosis and periosteal reactions in hepatic osteodystrophy.

    Main Methods:

    • Review of existing literature on hepatic osteodystrophy.
    • Analysis of vitamin D metabolism pathways in liver disease.

    Related Experiment Videos

  • Clinical observation of patient responses to supplementation.

    • Main Results:

    • Vitamin D deficiency is identified as the primary cause of osteomalacia.
    • Osteomalacia shows successful treatment with vitamin D supplementation.
    • Calcium, phosphorus, and magnesium supplements may benefit some patients.
    • The causes and treatments for osteoporosis and periosteal reactions are not yet understood.

    Conclusions:

    • Vitamin D supplementation effectively treats osteomalacia in hepatic osteodystrophy.
    • Further research is needed to understand and treat osteoporosis and periosteal reactions.
    • Hepatic osteodystrophy management requires addressing vitamin D deficiency and potential mineral imbalances.